Clik here to view.
Personalized Neuromodulation Treatment Significantly Slowed Alzheimer’s...
Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog11...
View ArticleSmall mid-stage trial suggests targeted magnetic pulses to brain could slow...
Patients receiving transcranial magnetic stimulation had slower disease progressionBy Jonathan WosenVIEW ARTICLE HERE The post Small mid-stage trial suggests targeted magnetic pulses to brain could...
View ArticleNoninvasive brain stimulation slows Alzheimer’s disease in yearlong trial
By Darren Incorvaia VIEW ARTICLE HERE As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a different, noninvasive approach to...
View ArticleAlzheimer’s researchers say brain stimulation device may slow symptoms
In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain network that stores memories and is typically hard hit by the disease.By Linda...
View ArticlePersonalized Noninvasive Neuromodulation Slows AD Progression
BY MEGAN BROOKSNew research supports the therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) for Alzheimer’s disease (AD).In a 52-week phase 2 trial, personalized rTMS applied...
View ArticleAre we entering a neurotechnology renaissance in healthcare?
BY CHARLOTTE HUFor Alzheimer’s, chronic pain, and depression, brain stimulation may help where drugs fail.A seemingly old-school tech for treating neurological disorders is gearing up for a comeback. A...
View ArticleClik here to view.
Sinaptica Announces Initiation of Co-Development of the SinaptiStim®...
Development is underway for March delivery of the first non-invasive investigational neuromodulation system in coordination with partners Nexstim and BittiumBuilding on the recently released positive...
View ArticleClik here to view.
Enrollment Initiated for Phase 2 Clinical trial in Early Alzheimer’s with...
Proprietary approach combines two neurostimulation modalities simultaneously, with the potential to enhance efficacy while reducing treatment time by 70%Recently published Phase 1 data in healthy...
View ArticleClik here to view.
Targeted Magnetic Stimulation Slows Alzheimer’s Progression in Phase II Study
BY GREG LAUBA personalized transcranial magnetic stimulation (TMS) protocol, designed to stimulate the precuneus within the default mode network, was well tolerated and significantly slowed clinical...
View ArticleEarly neurotechnology trials have seen some success. Here are the details.
BY CHARLOTTE HUHow different brain stimulation devices are being tested as an alternative to the standard of care. Neuromodulation technology, also known as neurotechnology, is making a return as a...
View ArticleClik here to view.
Positive Data Published in Alzheimer’s Research & Therapy from 12-month Phase...
Data showed strong separation from placebo and statistical significance in mild-to-moderate patients on key measures including CDR-SB, ADAS-Cog11, ADCS-ADL, and NPIPersonalized Neuromodulation (nDMN)...
View ArticleHow Personalized Repetitive Transcranial Magnetic Stimulation May Transform...
BY MARCO MEGLIO READ THE FULL ARTICLE The Alzheimer disease (AD) treatment pipeline is ever evolving, with numerous different modalities and targets currently being explored. In recent years, the field...
View Article